Publications in Scientific Journals by Mello Biotech & Affiliations

Mello Biotech values its innovation & intellectual properties as its most vital assets. The company strives to continuously strengthen its advantages through enforcing patents, publishing scientific articles, and developing better processes. Mello Biotech and its affiliations have claims to multiple patent and patent applications worldwide on the construction, modification, production and utility of microRNAs. Specifically, the firm focuses in stem cell reprogramming using microRNA, and innovative microRNA therapies that addresses unmet medical needs.